Legal Developments and the 2025 Roadmap Rule 702 Hearing Scheduled (May 14, 2025): This hearing will determine the admissibility of expert witness testimony regarding causation
WHY THIS MATTERS It is a major step for structured target discovery: turning large lists of aging genes into ranked, testable drug candidates
Leaky guts, he said, are a huge problem. While everyones guts are semi-permeable, when the lining of the intestines becomes damaged, it can let more than just water and nutrients seep through including toxins and bacteria that may escape into the bloodstream and fuel inflammation throughout the body
Of note, in the SURPASS-4 trial, adjudicated major adverse cardiovascular events (MACE) were not increased with tirzepatide compared with insulin glargine over an extended follow-up period of 52 additional weeks after the main trial period of 52 weeks [21]
A.SerafiniN.WinterD
In terms of reduction in TG levels, 9 studies (with 324 and 283 subjects from the experimental and control groups, respectively) were included for analysis
